Acumen Pharmaceuticals, Inc.

NASDAQ:ABOS

Biotechnology

Healthcare
$2.29 +0.67%

+$0.02 today

Market cap
$165.63M
Beta
0.35
P/E (TTM)
-1.3
EPS (TTM)
-$1.79
52W Low $1.10High $3.60

Volume 0.81M

Average 0.40M

Income Statement

Follow revenue through to earnings.

Revenue

$0.00

FY 2025 · Annual

Operating Income

-$123.83M

FY 2025 · Annual

Net Income

-$121.33M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00000
Cost of Revenue12.31M0000
Gross Profit(12.31M)0000
Gross Margin—————
Research & Development12.31M32.36M42.32M93.8M104.89M
Selling, General & Admin7.28M12.88M18.82M20.22M18.95M
Operating Expenses7.28M45.24M61.14M114.02M123.83M
Depreciation & Amortization4K169K184K178K184K
EBITDA(100.6M)(42.69M)(51.61M)(98.08M)(116.93M)
EBITDA Margin—————
Operating Income(19.58M)(45.24M)(61.14M)(114.02M)(123.83M)
Operating Margin—————
Interest Income84K2.39M10.79M14.32M7.45M
Interest Expense00581K4.07M4.22M
Other Income / Expenses(81.02M)2.38M8.77M11.69M2.5M
Income Before Tax(100.61M)(42.86M)(52.37M)(102.33M)(121.34M)
Pre-Tax Margin—————
Income Tax Expense00000
Net Income(100.61M)(42.86M)(52.37M)(102.33M)(121.34M)
Net Margin—————
EPS (Basic)(2.63)(1.06)(1.08)(1.71)(2.00)
EPS (Diluted)(2.63)(1.06)(1.08)(1.71)(2.00)
Weighted Avg Shares38.27M40.6M48.49M60.01M60.56M
Weighted Avg Shares (Diluted)38.27M40.6M48.61M60.01M60.56M

ABOS Earnings Waterfall · TTM

NASDAQ:ABOS · Revenue to Net Income

Key Ratios

EPS$-1.87
Gross Margin0.0%
Net Margin0.0%
P/E Ratio-1.1
P/S Ratio0.0

Analysis

$0 of revenue converted into -$113.3M of net income for the selected period. Gross margin is 0.0% and net margin is 0.0%, showing how much revenue survives after costs and taxes. EPS is $-1.87, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportSep 16, 2026
S-8S-8 filingAug 12, 2026
8-KCurrent reportAug 12, 2026
10-QQuarterly reportAug 12, 2026
4Statement of changes in beneficial ownershipJun 17, 2026

How much revenue does ABOS generate?

Acumen Pharmaceuticals, Inc. (ABOS) reported $0.00 of revenue in fiscal 2025.

Is ABOS profitable?

Acumen Pharmaceuticals, Inc. (ABOS) reported -$121.33M of net income.